Abstract A randomised controlled trial was conducted to investigate the ability of chlorpromazine to reduce intestinal secretion in cholera. Chlorpromazine had reduced loss of intestinal fluid in animals with diarrhoea induced by cholera toxin, and in a preliminary study the drug had reduced purging in patients with cholera.
Introduction
Of all enteric pathogens that produce acute diarrhoea in man, Vibrio cholerae induces the most dramatic illness. The mortality rate in untreated cases may be 5070%.O 2 The primary cause of death in cholera is dehydration, which in mild and moderate cases may be effectively treated with oral glucose-electrolyte solution; severely dehydrated patients with intense purging, however, require intravenous fluid.3 Drugs that would reduce the rate of fluid loss in cholera have been sought with a view to decreasing the need for intravenous fluid. Several drugs have been tested in animals and found to have antisecretory properties.,
The mechanism of fluid loss in cholera includes the production of a toxin by V cholerae which stimulates the activity of cellular adenylate cyclase in the intestine and increases the intraepithelial concentration of cyclic adenosine monophosphate.-Chlorpromazine effectively inhibits adenylate cyclase activity in various tissues.1' 14 In mice chlorpromazine reversed intestinal secretion induced by cholera toxin, heat labile Escherichia coli enterotoxin, or prostaglandin El, and in piglets the drug inhibited diarrhoea caused by toxicogenic E ccli." '17Furthermore, a preliminary study in patients with severe cholera also indicated that chlorpromazine reduced fluid loss by inhibiting intestinal secretion. We therefore decided to see whether the antisecretory effect of chlorpromazine in patients with cholera would be manifested in a larger, randomised controlled clinical trial and also if the drug would have an influence on other aspects of the disease such as vomiting and the duration of diarrhoea. A total of 46 patients were studied: nine were included in each of thetreatment groups given 4 mg/kg by mouth, 4mg/kg intramuscularly, and 1 mg/kg intramuscularly; seven were in the group given 1 mg/kg by mouth; and 12 served as controls.
Subjects and methods
Reduction in fluid loss after chlorpromazine was expressed as a percentage of the 16-hour basal rate-that is, the rate during the 16 hours before allocation to treatment-and compared with that in the controls for each consecutive eight-hour period from 16 hours after admission. Due to the wide variation in purging rate after chlorpromazine a logarithmic transformation was applied to stabilise the variances and all analyses carried out using transformed values. For each time period the purging rates of the five groups were compared using one-way analysis of variance. Data for the control and the treatment groups were also compared in relation to duration of diarrhoea, intravenous fluid requirements, frequency of vomiting, and clinical findings. Table I gives the clinical characteristics of patients in the control and four treatment groups. The groups were similar in age, sex, distribution, and other clinical variables. After intravenous rehydration patients were well maintained in fluid balance, as indicated by weight gain, urine output, and follow-up measurements of serum specific gravity.
Results
STOOL REDUCTION Figure 1 shows the reduction in stool output of the chlorpromazinetreated and control patients. Over the 16 hours before administration of chlorpromazine (not shown in fig 1) the mean basal rates of purging (±SEM) were similar in the drug-treated groups-430 1 11 ml (1 mg/kg by mouth), 537157 ml (4 mg/kg by mouth), 579 ± 83 ml (1 mg/kg intramuscularly), 481 127 ml (4 mg/kg intramuscularly)-and 500 ± 67 ml in the control group. During the first, second, and fourth eight-hour periods after chlorpromazine the purging rates in the combined four treatment groups were significantly lower than in the controls (p <0-005, p < 0-05, and p < 001, respectively). In the third eight-hour period, however, the difference between the treatment and control groups was not significant. Though differences between the four treatment groups were not significant, there was a tendency for a better effect with the higher dose (4 mg/kg) of chlorpromazine given by either route.
-100\p<0 005 Figure 2 shows the specific reductions in stool output of each chlorpromazine-treated group. These reductions were calculated by subtracting the percentage reductions in purging rate of the treatment groups from those of the control group during the corresponding periods. In patients given chlorpromazine by either route the drug produced a striking biphasic inhibition with separate peaks during the first and fourth eight-hour periods after administration.
Of all the patients treated with chlorpromazine either by mouth or intramuscularly, 20 (11 given 4 mg/kg; nine given 1 mg/kg) had basal purging rates exceeding 100 ml/kg/8 hours, which would have been difficult to balance with oral fluids alone. Within the first eight hours after the drug, however, 16 of these patients (nine given 4 mg/kg; seven given 1 mg/kg) had rates below 75 ml/kg/8 hours, which are almost always managed successfully with oral treatment. Out of nine control Plasma specific gravity Table II shows the duration of diarrhoea, frequency of vomiting, and requirement for intravenous fluid of patients in the treatment and control groups. After chlorpromazine the mean duration of diarrhoea was significantly reduced in each treatment group as compared with the duration in the controls (p < 0-001). Also in the treatment groups fewer patients vomited and the mean requirement for intravenous fluid per patient was significantly less than in the controls (p < 0 01). 
CLINICAL EFFECTS
The hypotensive effect of chlorpromazine was evaluated in nine well-hydrated patients given 4 mg/kg by mouth or intramuscularly. Before treatment the mean systolic and diastolic blood pressures were 130 and 85 mm Hg respectively. During the first eight hours after chlorpromazine the lowest recorded readings were 125 and 80 mm Hg respectively. The mean of the differences between horizontal and erect blood pressures also did not differ before and after administration of the drug (4 v 6 mm Hg). There was no appreciable change in radial pulse, respiratory rate, and oral temperature after any of the given doses of chlorpromazine.
Discussion
This study supports the preliminary observations on the antisecretory effect of chlorpromazine in patients with cholera. 22 The drug, which effectively reduces fluid loss in mice and piglets,'5-17 was also effective in man at comparable doses. The antisecretory effect of the drug began within two hours of administration and continued through the first two eight-hour periods. A second peak of inhibition was observed during the fourth eight-hour period (24-32 hours) . This pattern of bimodal inhibitory response was seen in each of the four treatment groups. Though we cannot explain this biphasic response, the first peak probably reflects a toxin-antagonising effect of chlorpromazine, whereas the second may be due to the generation of some metabolite of the drug which also has antisecretory activity.23 Alternatively, the second peak might reflect the weak antibacterial action of chlorpromazine. Further studies will be needed to examine these hypotheses.
Though there was no significant difference in response between groups given 4 mg/kg and 1 mg/kg, there was a tendency for a lower purging rate in the higher-dose group. This finding is consistent with the dose-response studies in animals: in mice 4 mg/kg gave complete and 15 mg/kg gave half-maximal inhibition of the secretory response to a high dose of cholera toxin. 15 The mechanism by which chlorpromazine reduces fluid loss in cholera-has not been established but may include inhibition of adenylate cyclase activity in the intestinal mucosa.3 1" There may, however, be other effects as well.'5 Chlorpromazine reportedly modifies several cell membrane functions, such as expansion of the lipid bilayer and release of calcium ions.24 It also inhibits intestinal membrane protein kinase activities."5 All these effects, alone or in combination, may interfere with the membrane transport process. A unifying hypothesis linking the observed inhibition of adenylate cyclase activity to a postulated action of chlorpromazine on the calcium-binding protein calmodulin in intestine25 26 has been advanced to explain the antisecretory effect. '7 Our results indicate that chlorpromazine is also effective in reducing the duration of diarrhoea, frequency of vomiting, and requirements for intravenous fluid, which are important determinants of the disease. Use of the drug in cholera might therefore obviate the need for much intravenous fluid and simplify rehydration procedures, particularly in a rural outbreak. Children with intense vomiting are especially difficult to manage with oral rehydration fluids, and use of chlorpromazine in these cases may be more beneficial. The standard treatment of cholera, however, is still rehydration fluid and tetracycline, and whether chlorpromazine can further simplify these treatment procedures in a more practical way needs to be determined. Sedation from the drug could be one limitation of its usefulness. The sedative effect of chlorpromazine was manifested by mild drowsiness, which gradually improved over four to six hours. In children, however, an optimal antisecretory dose of the drug might produce stronger sedation and interfere with the intake of oral rehydration fluid. Hence the ability of chlorpromazine to reduce the failure rate in patients with cholera rehydrated by mouth, especially children, needs to be examined. Also, further studies to determine whether the antisecretory effect of the drug extends to non-cholera diarrhoea-for example, toxicogenic E coli diarrhoea-would be particularly important, since E coli is a major diarrhoeal agent in many parts of the world.
(Accepted 11 February 1982) OF FEVERS IN GENERAL.
AS more than one half of mankind is faid to perifh by fevers, it is of importance to be acquainted with their caufes. The moft general caufes of fevers are, infec7ion, errors in diet, unwholefome air, violent emotions ofthe mind, fuppreffion of ufual evacuations, external or internal injuries, and extreme degrees of heat or cold. As moft of thefe have already been treated of at confiderable length, and their effeds fhewn, we shall not now refume the confideration of them, but fhall only recommend it to all, as they would wifh to avoid fevers and other fatal difeafes, to pay the moft punEtual attention to thefe articles. WHEN the fever attacks fuddenly, it always begins with an uneafy fenfation of exceffive cold, accompanied with debility and lofs of appetite; frequently the cold is attended with fhivering, oppreffion about the heart, and ficknefs at ftomach, or vomiting.
FEVERS are divided into continual, remitting, intermitting, and fuch as are attended with cutaneous eruption or topical inflammation, as the fmall-pox, eryfipelas, &c. By a continual fever is meant that which never leaves the patient during the whole courfe of the difeafe, or which fhews no remarkable increafe or abatement in the fymptoms. This kind of fever is likewife divided into acute, flow, and malignant. The fever is called acute when its progrefs is quick, and the fymptoms violent; but when thefe are more gentle, it is generally denominated flow. When livid or petechial fpots fhew a putrid ftate of the humours, the fever is called malignant, putrid, or petechial.
A REMITTING fever differs from a continual only in degree. It has frequent increafes and decreafes, or exacerbations and remiffions, but never wholly leaves the patient during the courfe of the difeafe. Intermitting fevers, or agues, are thofe which, during the time that the patient may be faid to be ill, have evident intervals or remiflions of the fymptoms.
As a fever is only an effort of Nature to free herfelf from an offending caufe, it is the bufinefs of thofe who have the care of the fick, to obferve with diligence which way Nature points, and to endeavour to affift her operations. Our bodies are fo framed, as to have a conflant tendency to expel or throw off whatever is injurious to health. This is generally done by urine, fweat, flool, expedloration, vomit, or fome other evacuation.
MANY of thofe who follow fedentary employments are conflantly in a bending pofture, as fhoemakers, taylors, cutlers, &c. Such a fituation is extremely hurtful. A bending poflure obflru6ls all the vital motions, and of courfe muft deftroy the health. Accordingly we find fuch artificers generally complaining ofindigeftions, flatulencies, head-achs, pains of the breaft, &c.
THE aliment in fedentary people, inflead of being pufhed forwards by an eredt pofture, and the a&tion of the mufcles, is in a manner confined in the bowels. Hence indigeflions, coftivenefs, wind, and other hypochondriacal affedions, the conftant companions of the fedentary. Indeed none of the excretions can be duly performed where exercife is wanting; and when the matter which ought to be difcharged in this way, is retained too long in the body, it muft have bad effeEls, as it is again taken up into the mafs of humours.
A BENDING poflure is likewife hurtful to the lungs. When thiis organ is compreffed, the air cannot have free accefs into all its parts, fo as to expand them properly. Hence tubercles, adhefions, &c. are .formed, which often end in confumptions. Befides, the proper aEtion of the lungs being abfolutely neceffary for making good blood, when that organ fails, the humours foon become univerfally depraved, and the whole conflitution goes to wreck. (Buchan's Domestic Medicine, 1786.) 
